Showing results (1481-1490 of 2,477) with videos related to
Sort By:
Pageof 248
International Journal of Environmental Research and Public Health|May 21, 2020
A Comparison between Cigarette Topography from a One-Week Natural Environment Study to FTC/ISO, Health Canada, and Massachusetts Department of Public Health Puff Profile StandardsRisa J Robinson, S Emma Sarles, Shehan Jayasekera, et al.Annals of Hematology|July 31, 2008
Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trialMathias Witzens-Harig, Monika Reiz, Christiane Heiss, et al.Veterinary Microbiology|July 9, 2018
Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) among employees and in the environment of a small animal hospitalAndrea T Feßler, Riccarda Schuenemann, Kristina Kadlec, et al.European Journal of Haematology|May 4, 2017
Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS studyMarcel Reiser, Michael Borte, Dörte Huscher, et al.Leukemia & Lymphoma|April 15, 2014
Pentostatin, cyclophosphamide and rituximab is a safe and effective treatment in patients with Waldenström's macroglobulinemiaIsabelle Herth, Manfred Hensel, Michael Rieger, et al.Cytotherapy|November 2, 2013
Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cellsKazushi Tanimoto, Pawel Muranski, Samantha Miner, et al.Magnetic Resonance in Medicine|October 16, 2018
Magnetic resonance field fingerprintingGregor Körzdörfer, Yun Jiang, Peter Speier, et al.The Journal of Chemical Physics|June 21, 2012
High pressure study of molecular dynamics of protic ionic liquid lidocaine hydrochlorideA Swiety-Pospiech, Z Wojnarowska, J Pionteck, et al.European Journal of Haematology|March 25, 2010
Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapyFabienne McClanahan, Thomas Hielscher, Michael Rieger, et al.Computational and Structural Biotechnology Journal|November 16, 2022
Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in Toxoplasma gondiiKim Chi Vo, Liberta Ruga, Olympia Ekaterini Psathaki, et al.Pageof 248